Clinical trial
VELCADEXA: Velcade and Dexamethasone in Multiple Myeloma
NCT00391157 · PETHEMA Foundation, Other · Completed
Key facts
| NCT number | NCT00391157 |
|---|---|
| Title | VELCADEXA: Velcade and Dexamethasone in Multiple Myeloma |
| Official title | VELCADEXA: A National, Multi-Center, Open-Label Study of Pretransplant Induction With Alternating VELCADE and Dexamethasone (VEL/Dex) in Younger (< 65 Yrs) Untreated Multiple Myeloma Patients. |
| Lead sponsor | PETHEMA Foundation, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Multiple Myeloma |
| Intervention type | Drug |
| Interventions | Velcade/Dexamethasone |
| Enrollment | 40 |
| Start date | Aug 1, 2005 |
| Primary completion | Jun 1, 2007 |
| Completion | Jan 1, 2008 |
| First posted | Oct 23, 2006 |
| Last update posted | Sep 18, 2009 |
| Countries | Spain |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: